TrialJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2020

LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors.

Bo Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.